Priority Date: 18.07.13 (US 201361856005P)

QUINAZOLINE DERIVATIVES, COMPOSITIONS THEREOF, AND USE AS PHARMACEUTICALS

  • Application ID: EP14825785
  • Status: GRANT OF PATENT INTENDED

Attorney

no operation time available
Headquarter in Bristol and 7 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 232 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 18.07.2013 - Priority Date (US 201361856005P)
  • 22.01.2015 - Publication A1 (WO2015007219)
  • 25.05.2016 - Publication A1 (EP3022186)